Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

HCW Biologics (HCWB) Profit After Tax (2021 - 2025)

Historic Profit After Tax for HCW Biologics (HCWB) over the last 5 years, with Q3 2025 value amounting to -$4.6 million.

  • HCW Biologics' Profit After Tax fell 1670.94% to -$4.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$12.1 million, marking a year-over-year increase of 6771.53%. This contributed to the annual value of -$30.0 million for FY2024, which is 2012.28% down from last year.
  • According to the latest figures from Q3 2025, HCW Biologics' Profit After Tax is -$4.6 million, which was down 1670.94% from -$1.9 million recorded in Q2 2025.
  • HCW Biologics' Profit After Tax's 5-year high stood at -$1.9 million during Q2 2025, with a 5-year trough of -$15.3 million in Q2 2024.
  • Its 5-year average for Profit After Tax is -$4.8 million, with a median of -$3.9 million in 2022.
  • In the last 5 years, HCW Biologics' Profit After Tax plummeted by 25498.84% in 2024 and then surged by 8738.41% in 2025.
  • HCW Biologics' Profit After Tax (Quarter) stood at -$3.2 million in 2021, then tumbled by 70.75% to -$5.4 million in 2022, then plummeted by 97.1% to -$10.7 million in 2023, then surged by 68.42% to -$3.4 million in 2024, then tumbled by 35.01% to -$4.6 million in 2025.
  • Its Profit After Tax was -$4.6 million in Q3 2025, compared to -$1.9 million in Q2 2025 and -$2.2 million in Q1 2025.